All Recombinant Proteins Are Not the Same: From Antigens to Avi-tags
Scientist
Date: August 12, 2020. Time: 11:00 AM EST.
In mid-August, the Bio-Techne team shared their vast industry expertise in a webinar focusing on recombinant protein selection, customization and application. The featured panelists — Bio-Techne’s Martin Ramsden, Director Commercial Development and John Humphrey, Director Molecular and Cellular Biology — presented on recombinant protein applications, specifically biotinylated proteins, including site-specific Avi-tag biotinylation. Humphrey also spoke at length about COVID-19 SARS proteins available through Bio-Techne.